Tag: p-tau217
-
Digital Test Plus Blood Biomarker Improves Primary Care Alzheimer’s Diagnosis
New Frontline Approach to Alzheimer’s Diagnosis in Primary Care A two-step strategy combining a brief, self-administered digital cognitive test with a targeted blood biomarker panel dramatically improves the accuracy of Alzheimer’s disease (AD) diagnosis in everyday clinics. The approach, validated in a recent Nature Medicine study, shows that confirming cognitive impairment before ordering amyloid blood…
-
Digital test plus blood biomarker boosts accuracy of Alzheimer’s diagnosis in primary care
Two-step workflow taps cognitive screening before biomarker testing A new two-step approach to diagnosing Alzheimer’s disease (AD) in primary care shows promise for cutting false positives and streamlining referrals. Researchers tested a brief, self-administered digital cognitive battery, BioCog, first, and reserved amyloid-related blood tests for individuals who showed objective impairment. This “test-then-blood” workflow aims to…